IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

TRV GP II, LLC

Q4 2018 Holdings

Filed 2019-01-28 | 4 holdings | $100.6K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Blueprint Medicines Corporation(2L9)COM09627Y109$47.4K878,87547.1%
Jounce Therapeutics, Inc.(JNCEEUR)COM481116101$34.5K10,230,34934.3%
Allena Pharmaceuticals, Inc.(ALNAEUR)COM018119107$15.2K2,790,96415.1%
Sage Therapeutics, Inc.(SG7)COM78667J108$3.6K37,3623.6%